URL copied
Tamil Nadu allows Chinese Covid vaccine makers to bid unlike Mumbai
Tamil Nadu government s global tender for 3.5 crore doses of Covid-19 vaccine does not restrict Chinese vaccine makers from bidding, said an official. We are allowing every product (vaccine) as long as it is approved by the World Health Organisation (WHO) and licensed by the Drugs Controller General of India (DGCI), a senior official told IANS.
According to the official, about six vaccines have been approved by WHO and three by DCGI.
On the other hand, the Brihanmumbai Municipal Corporation in its one crore vaccine dose tender has disqualified companies located in countries sharing borders with India from participating in the bid, thus disqualifying Chinese vaccine manufacturers.
Source:
Highlights
Tamil Nadu government`s global tender for 3.5 crore doses of Covid-19 vaccine does not restrict Chinese vaccine makers from bidding. We are allowing every product (vaccine) as long as it is approved by the World Health Organisation (WHO) and licensed by the Drugs Controller General of India (DGCI), a senior official said.
Chennai: Tamil Nadu government`s global tender for 3.5 crore doses of Covid-19 vaccine does not restrict Chinese vaccine makers from bidding, said an official. We are allowing every product (vaccine) as long as it is approved by the World Health Organisation (WHO) and licensed by the Drugs Controller General of India (DGCI), a senior official told IANS.
TN allows Chinese Covid vaccine makers to bid unlike Mumbai
Sun, May 16 2021 13:33 IST |
2 Views
Pak approves Sinopharm Covid vaccine for emergency use. Image Source: IANS News
Chennai, May 16 : Tamil Nadu government s global tender for 3.5 crore doses of Covid-19 vaccine does not restrict Chinese vaccine makers from bidding, said an official. We are allowing every product (vaccine) as long as it is approved by the World Health Organisation (WHO) and licensed by the Drugs Controller General of India (DGCI), a senior official told IANS.
According to the official, about six vaccines have been approved by WHO and three by DCGI.
On the other hand, the Brihanmumbai Municipal Corporation in its one crore vaccine dose tender has disqualified companies located in countries sharing borders with India from participating in the bid, thus disqualifying Chinese vaccine manufacturers.
As the company is currently facing manpower challenges, Medical syringe major Hindustan Syringes and Medical Devices Ltd (HMD) on Saturday said that it is hiring more people to meet the target of producing 1 billion syringes by June.The company .
Image source: Getty Images
EMVision Medical Devices Ltd(ASX: EMV) shares were on the rise today following news of two significant technology and product development breakthroughs from the company.
By the market’s close, the EMVision share price was trading at $3.16, up 4.29% from yesterday’s closing price of $3.03.
Let’s take a closer look at the latest news from EMVision.
What’s driving the EMVision share price?
EMVision shares responded positively today after the company announced it has developed two new technologies. These will work alongside its prototype portable electromagnetic (EM) imaging device, currently being developed as a brain scanner.